Origami Therapeutics, Inc.

Origami Therapeutics, Inc. is focused on developing innovative therapies aimed at treating neurodegenerative diseases through the targeted degradation of disease-related proteins. The company is pioneering next-generation protein degraders and correctors that specifically address the underlying causes of conditions such as Alzheimer's disease, Huntington's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Frontotemporal Dementia. By utilizing a unique approach to protein degradation, Origami Therapeutics aims to offer new treatment options that modify the disease process r…